Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient Dornase alfa, ATC R05CB13 for the period 01.07.2024 - 30.06.2026
About This Opportunity
This is a supplies contract in the health and medical services sector. Located in Germany, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Auto-translated from GermanDAK-Gesundheit assumes that this procedure does not fall within the scope of cartel procurement law due to a lack of selection decision and thus the non-discriminatory access for all pharmaceutical companies. Regardless, it automatically ends upon the entry into force of the exclusive contract for Dornase alfa, ATC R05CB13, as a result of a formal award procedure according to the regulations of the 4th part of the GWB with one or more contracting partners. In order to do justice to the diversity of potential contracting partners within the framework of the approval model, every pharmaceutical company is enabled to conclude a framework agreement at any time and under the same conditions during the contract period. The necessary contractual documents for this are available for download via the online portal www.dtvp.de/center under the link mentioned in 5.1.11. Prerequisites for the conclusion, or later accession to the contracts, which first come into force on 01.07.2024, are the complete and timely submission of the following documents (available for download under the link mentioned in 5.1.11.) to the following department at DAK-Gesundheit: 1. Offer letter 2. Acceptance of the contractual provisions of DAK-Gesundheit, especially also the specified discounts by submitting the contract signed by name or company stamp by the interested party in the designated place. 3. The completed appendices 1 and 2 to the contract. The interested party must enter the medicinal products for the above-mentioned active ingredient here, which are to become the subject of the contract. The documents are to be submitted PER EMAIL to: openhouse@dak.de DAK-Gesundheit Department for Medicinal Products (0038 00) Nagelsweg 27-31 20097 Hamburg Appendix 2 must be explicitly sent as an Excel file to the email address openhouse@dak.de. Contracts within the framework of this model and for the above-mentioned active ingredient will be concluded for the first time with effect from 01.07.2024 and will end on 30.06.2026. Interested parties who wish to become contracting partners by this date must submit the above-mentioned documents to be submitted by the 5th of the preceding month PER EMAIL. The offer must be submitted in text form as an electronic offer PER EMAIL to openhouse@dak.de. Submission of the offer by post is not planned in this procedure. Please DO NOT submit the offer via the German Procurement Portal. For timely submission, electronic receipt of the complete documents PER EMAIL to the email address openhouse@dak.de is sufficient. Later accessions are possible at any time. In order to be able to join on the 1st or 15th of the following month during the contract period, the above-mentioned documents must be available to DAK-Gesundheit by the 5th of the preceding month, regardless of the desired accession. Here too, timely receipt by email at DAK-G is crucial. Example: The accession desired by the bidder is to take place on 15.07. (following month), the documents would have to be available by 05.06. (preceding month). Note: The publication is made here using the form for open procedures. As already made clear, this is not such a procedure - the notice had to be used for technical reasons, as there is no suitable form for approval procedures.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on July 3, 2026. Last refreshed 16 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About DAK-Gesundheit
DAK-Gesundheit has issued 215 procurement notices on BidsFactory, including 118 currently open and 59 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), service.bund.de (Germany), and DÖE Bekanntmachungsservice (Germany). Most recent publication: July 17, 2026.
Frequently asked questions about this tender
What is the estimated budget?
The estimated contract value is €1 - €1. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to 1 4 U Pharma GmbH; 1 0 1 Carefarm GmbH; Abacus Medicine A/S; axicorp Pharma B.V.; EurimPharm Arzneimittel GmbH. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by DAK-Gesundheit in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.